CANF

Can-Fite Biopharma Ltd ADR

$0.62

-0 (-0.26%)

Analyst Overview

Target Price:

Date: 07.10.2025

$4.50

(+627.68%)

Strong Buy: 0

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

Description:

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutics for the treatment of cancer, liver and inflammatory diseases, COVID-19, and erectile dysfunction. The company is headquartered in Petah-Tikva, Israel.

Exchange:

NYSE MKT

Country:

USA

Sector:

HEALTHCARE

Industry:

BIOTECHNOLOGY

Address:

26 BEN GURION STREET, RAMAT GAN, ISRAEL, 5257346

Fiscal year end:

December

Market capitalization:

$14.6 Million

EBITDA:

-$8.91 Million

PERatio:

0.0

EPS:

0.0

Dividend per share:

$0.00

Dividend yield:

0.0%

Beta:

0.079

Dividends for 10 years

Income Statements for 10 years

Earnings calender

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:

$1,000

How much will you earn in 10 years:

-100%

How much will you get:

Prices dates:

30-09-2015: $621.00 and 30-09-2025: $0.62